119 related articles for article (PubMed ID: 36993276)
1. Dynamic phosphatase-recruitment controls B-cell selection and oncogenic signaling.
Lee J; Robinson ME; Sun R; Kume K; Ma N; Cosgun KN; Chan LN; Leveille E; Geng H; Vykunta VS; Shy BR; Marson A; Katz S; Chen J; Paietta E; Meffre E; Vaidehi N; Müschen M
bioRxiv; 2023 Mar; ():. PubMed ID: 36993276
[TBL] [Abstract][Full Text] [Related]
2. What goes up must come down: A tripartite Dok-3/Grb2/SHIP1 inhibitory module limits BCR signaling.
Reth M; Gold MR
Eur J Immunol; 2016 Nov; 46(11):2507-2511. PubMed ID: 27813071
[TBL] [Abstract][Full Text] [Related]
3. SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker.
Wu W; Lu P; Patel P; Ma J; Cai KQ; Mallikarjuna VS; Poureghbali S; Nakhoda SR; Nejati R; Lynn Wang Y
Oncogene; 2023 Feb; 42(6):409-420. PubMed ID: 36482202
[TBL] [Abstract][Full Text] [Related]
4. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
5. Non-Muscle Myosin II Is Essential for the Negative Regulation of B-Cell Receptor Signaling and B-Cell Activation.
Seeley-Fallen MK; Lazzaro M; Liu C; Li QZ; Upadhyaya A; Song W
Front Immunol; 2022; 13():842605. PubMed ID: 35493485
[TBL] [Abstract][Full Text] [Related]
6. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling.
Pani G; Kozlowski M; Cambier JC; Mills GB; Siminovitch KA
J Exp Med; 1995 Jun; 181(6):2077-84. PubMed ID: 7539038
[TBL] [Abstract][Full Text] [Related]
7. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
[TBL] [Abstract][Full Text] [Related]
8. Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks.
Sundaravel S; Kuo WL; Jeong JJ; Choudhary GS; Gordon-Mitchell S; Liu H; Bhagat TD; McGraw KL; Gurbuxani S; List AF; Verma A; Wickrema A
Clin Cancer Res; 2019 Sep; 25(18):5638-5649. PubMed ID: 31308061
[TBL] [Abstract][Full Text] [Related]
9. Actin-binding protein 1 links B-cell antigen receptors to negative signaling pathways.
Seeley-Fallen MK; Liu LJ; Shapiro MR; Onabajo OO; Palaniyandi S; Zhu X; Tan TH; Upadhyaya A; Song W
Proc Natl Acad Sci U S A; 2014 Jul; 111(27):9881-6. PubMed ID: 24958882
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement.
Owaidah TM; Rawas FI; Al Khayatt MF; Elkum NB
Hematol Oncol Stem Cell Ther; 2008; 1(1):34-7. PubMed ID: 20063526
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcgammaRIIb with Fc-engineered antibodies.
Chu SY; Vostiar I; Karki S; Moore GL; Lazar GA; Pong E; Joyce PF; Szymkowski DE; Desjarlais JR
Mol Immunol; 2008 Sep; 45(15):3926-33. PubMed ID: 18691763
[TBL] [Abstract][Full Text] [Related]
12. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
Nakamura K; Cambier JC
J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
[TBL] [Abstract][Full Text] [Related]
13. TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
Whillock AL; Ybarra TK; Bishop GA
J Biol Chem; 2021; 296():100465. PubMed ID: 33639170
[TBL] [Abstract][Full Text] [Related]
14. Failed down-regulation of PI3K signaling makes autoreactive B cells receptive to bystander T cell help.
Fiske BE; Getahun A
bioRxiv; 2023 Jan; ():. PubMed ID: 36747655
[TBL] [Abstract][Full Text] [Related]
15. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R
Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673
[TBL] [Abstract][Full Text] [Related]
16. PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA).
Akman B; Hu X; Liu X; Hatipoğlu T; You H; Chan WC; Küçük C
J Leukoc Biol; 2021 May; 109(5):901-914. PubMed ID: 33145806
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory Receptor Trap: A Platform for Discovery of Inhibitory Receptors That Utilize Inositol Lipid and Phosphotyrosine Phosphatase Effectors.
Crute BW; Sheraden R; Ott VL; Harley ITW; Getahun A; Cambier JC
Front Immunol; 2020; 11():592329. PubMed ID: 33193438
[TBL] [Abstract][Full Text] [Related]
18. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
19. The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation.
Isnardi I; Bruhns P; Bismuth G; Fridman WH; Daëron M
Immunol Lett; 2006 Apr; 104(1-2):156-65. PubMed ID: 16406061
[TBL] [Abstract][Full Text] [Related]
20. Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
Sarmay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1997 Jun; 57(1-3):159-64. PubMed ID: 9232445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
